| INTRODUCTION
As it is clearly demonstrated in Humans, canine lymphomas represent a group of heterogeneous neoplasms with different clinical course and prognosis. They are part of the most encountered cancers, with reported average incidence between 20 and 107 per 100 000 dogs and represent between 12% and 18% of all canine cancers. [1] [2] [3] [4] [5] [6] Canine lymphomas are clinical and morphological entities. Their classification is based on clinical presentation, cell morphology, grade, immunophenotype and eventually genome analysis.
Classification of lymphomas according to the morphology of lymphomatous cells, either at cytology or at histopathology, is complex.
Many different schemes were used in the past, because of updated knowledge and studies regarding morphology, lymphoid differentiation, immunology, immunogenetic and finally the application of molecular biology testing. 7 Numerous classification schemes have been evaluated in veterinary literature. 2, [8] [9] [10] [11] [12] World Health Organization (WHO) classification is the current standard for diagnosis in humans and is constantly evolving. 13 This classification was adapted to the dog, and more than 30 different morphotypes of canine lymphomas are currently identified. 2, 9, 11, 12, 14, 15 Correlation between morphotypes and prognosis presented discordant results in literature, leading to some dilemma for the interpretation of laboratory reports, and application in clinical practice. That is probably why many veterinarians, including some oncologists, continue to ignore the prognostic impact of morphotype of canine lymphomas.
The aim of this article was to present a systematic review of the prognostic significance of morphological classifications of canine lymphomas. A standardized method was applied in order to evaluate the state of knowledge. † Present address: Oncology and Internal Medicine department, Clinique Veterinaire Occitanie, 185 avenue des Etats-Unis, 31200 Toulouse, France.
| METHODS
Methods for searching and analysing relevant literature, and for extracting data were adapted from the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA statement). 16, 17 
| RESULTS
The search of databases provided a total of 204 citations. Seven additional records were identified through analysis of references.
After adjusting for duplicates, 184 remained. On these, 111 studies were discarded because of the identification of exclusion criteria Table 2) . One study that used Anderson Hospital nomenclature for neoplastic diseases was excluded from final analysis because of the non-specificity for lymphoid neoplasm of this nomenclature. 26 Moreover, 1 study evaluating response to a multi-agent chemotherapy protocol was excluded because it focused only on immunophenotype, and not on morphology. 27 Finally, 10 studies met all inclusion criteria. A flow diagram of study selection was presented in Figure 1 .
All included studies considered canine lymphomas as clinical and morphological entities. However, some of them did not reported epidemiological and clinical data, leading to heterogeneity in each studied population, which could interact with prognosis. Thus, staging, (Tables 4 and 5 ).
The updated Kiel classification was correlated with clinical presentation in 4 different studies (Table 6) . 11, 15, 21, 23 Thus, dogs with lymphoblastic lymphomas were more often diagnosed in stage-V, and paraneoplastic hypercalcemia was more often associated with lymphoblastic and peripheral T-cell lymphomas. In another study pub- was independently associated with a higher chance to survive more (Table 7) .
Lurie et al reported repartition of morphotypes in 43 boxer dogs (EBM level 2b). 22 In the studied population, 17 dogs had The study demonstrated a correlation between morphology and clinical presentation: predisposition of lymphoblastic variant to present stage-V; predisposition of pleomorphic mixed, pleomorphic large cell and lymphoblastic to present hypercalcemia This classification demonstrated good (83%) overall accuracy between different pathologists is reported, even if lack of repeatability (40%-87%) was present in the diagnosis of some morphotypes. In the same way, therapeutic management of canine lymphoma evolved greatly over the year, and could potentially bias the outcome.
Prognostic in canine lymphomas is fundamentally dependent on the Limits of evidence-based medicine in veterinary sciences are mainly because of lack of randomized controlled trial, and to the relative lack of prospective controlled studies. Thus in this review, no EBM level 1 studies were identified, and most of the studies were classified in EBM level 2b and 2c. Moreover, we analysed only published studies available in MEDLINE and in English. Thus, some data could be lacking. In addition, the findings from significant prognosis of classification are more likely to be published if the results are statistically significant, 17 and could contribute to a bias of publication. 
| CONCLUSION

